Bsense Bio Therapeutics

Bsense Bio TherapeuticsBsense Bio Therapeutics
Bsense Bio Therapeutics

Bsense Bio Therapeutics

Developing small molecules to treat sensory hyperexcitability disorders like pain and tinnitus.

Website
DR 0.42018Active3
Rate
Advertise here

About

Bsense Bio Therapeutics is a biotechnology company focused on developing novel small molecule therapeutics for disorders characterized by sensory hyperexcitability. Their innovative approach aims to target multiple mechanisms of hyperexcitability with a single compound, potentially leading to greater efficacy and improved safety profiles for conditions such as chronic pain, tinnitus, and pruritus.
Frequently asked

What does Bsense Bio Therapeutics do?

Bsense Bio Therapeutics is a biotechnology company focused on developing novel small molecule therapeutics for disorders characterized by sensory hyperexcitability. Their innovative approach aims to target multiple mechanisms of hyperexcitability with a single compound, potentially leading to greater efficacy and improved safety profiles for conditions such as chronic pain, tinnitus, and pruritus.

What is Bsense Bio Therapeutics's revenue?

StartupHub estimates Bsense Bio Therapeutics's annual revenue at $479K (range $286K to $800K, 64% confidence), based on comparable companies in the sector.

When was Bsense Bio Therapeutics founded?

Bsense Bio Therapeutics was founded in 2018.

What industry does Bsense Bio Therapeutics operate in?

Bsense Bio Therapeutics operates in Life Sciences, Biotech, Drug Discovery, Neurology, Therapeutics, HealthTech.

How many employees does Bsense Bio Therapeutics have?

Bsense Bio Therapeutics has approximately 3 people on record.

HEADCOUNT
3
DOMAIN RATING
0.4
Comments

No comments yet. Be the first to share your take.